VFA
TTPH

Virtus Fund Advisers’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Virtus Fund Advisers’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$376K Buy
+2,982
New +$382K ﹤0.01% 376
2014
Q3 		– Sell
-94
Closed -$25K – 2219
2014
Q2 		$25K Buy
+94
New +$20.2K ﹤0.01% 2314

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's TTPH Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017: 2,982 shares worth $376K. The stake represents ﹤0.01% of the portfolio and ranks #376 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in TTPH as recently as Q2 2014.

Virtus Fund Advisers first reported a position in TTPH in Q2 2014 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • Virtus Fund Advisers held 2,982 shares of Tetraphase Pharmaceuticals, Inc. worth $376K as of Q4 2017.
  • Tetraphase Pharmaceuticals, Inc. was a new Virtus Fund Advisers position in Q4 2017.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #376 holding.
  • Virtus Fund Advisers first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.